COMPARISON OF LYMPHOTRACK® MISEQ® ASSAYS AND FLOW CYTOMETRY FOR CLONALITY AND MINIMUM RESIDUAL DISEASE ASSESSMENT IN MULTIPLE MYELOMA

EHA Library, Austin Jacobsen, 215624

QUALITY OF HEMATOLOGIC RESPONSE BUT NOT DEPTH OF NT-PROBNP RESPONSE IMPROVES SURVIVAL OF PATIENTS WITH AL AMYLOIDOSIS WHO ACHIEVE CARDIAC RESPONSE

EHA Library, Paolo Milani, 215625

SUSTAINED MRD NEGATIVITY AT 12 MONTHS POST-ASCT PREDICTS OUTCOMES FOR MYELOMA PATIENTS: A REAL WORLD STUDY.

EHA Library, Michael Austin, 215626

MULTIPLE MYELOMA IN PATIENTS UNDER 40 YEARS OLD: A RETROSPECTIVE ANALYSIS FROM THE INTERGOUPE FRANCOPHONE DU MYELOME (IFM).

EHA Library, Alexis Caulier, 215627

AMPLICON NEXT-GENERATION SEQUENCING (NGS) OF REARRANGED IMMUNOGLOBULIN (IG) LOCI IS ADVANTAGEOUS FOR CLONAL MARKER IDENTIFICATION AND MINIMAL RESIDUAL DISEASE (MRD) DETECTION IN MULTIPLE MYELOMA (MM).

EHA Library, Michaela Kotrová, 215628

A PHASE 1B STUDY USING THE COMBINATION OF SELINEXOR, DARATUMUMAB, AND DEXAMETHASOME IN MULTIPLE MYELOMA PATIENTS PREVIOUSLY EXPOSED TO PROTEASOME INHIBITORS AND IMMUNOMODULATORY DRUGS

EHA Library, Cristina Gasparetto, 215629

A REAL WORLD RETROSPECTIVE ANALYSIS OF EXTRAMEDULLARY DISEASE FROM BALKAN MYELOMA STUDY GROUP AND BARCELONA UNIVERSITY: CLINICAL FEATURES AND OUTCOME

EHA Library, MERAL BEKSAC, 215630

AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN AL AMYLOIDOSIS: SURVIVAL IMPROVEMENT IN DIFFERENT RISK CATEGORIES IN A SINGLE CENTER EXPERIENCE


EHA Library, ANGELO BELOTTI, 215631

COMPARABLE OUTCOMES USING PROPYLENE GLYCOL-FREE MELPHALAN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

EHA Library, Kevin Miller, 215632

ACTIVITY AND SAFETY OF DARATUMUMAB MONOTHERAY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA REQUIRING DIALYSIS: PRELIMINARY RESULTS OF A SPANISH, RETROSPECTIVE, MULTICENTER TRIAL

EHA Library, Maria Jose cejalvo, 215633

OPTIMISING TREATMENT FOR HIGH-RISK MYELOMA IN A STRATIFIED MULTI-CENTRE TRIAL: EXPERIENCE FROM MUKNINE OPTIMUM STUDY

EHA Library, Martin Kaiser, 215634

ASYMPTOMATIC HEART INVOLVEMENT IN AL AMYLOIDOSIS

EHA Library, Marco Basset, 215635

RANDOMIZED CLINICAL TRIAL (RCT) REPRESENTATIVENESS & OUTCOMES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REAL WORLD (RW) PATIENTS: COMPARISON OF ASPIRE, TOURMALINE-MM1, POLLUX, & ELOQUENT RCTS

EHA Library, Dorothy Romanus, 215636

PHARMACOKINETIC EVALUATION OF TEST DOSE PREDICTIONS OF HIGH DOSE MELPHALAN EXPOSURE IN PATIENTS WITH MULTIPLE MYELOMA.

EHA Library, Judith Trotman, 215637

A PHASE II STUDY OF SELINEXOR(KPT-330) COMBINED WITH BORTEZOMIB AND DEXAMETHASONE (SVD) FOR INDUCTION AND CONSOLIDATION FOR PATIENTS WITH PROGRESSIVE OR REFRACTORY MULTIPLE MYELOMA: THE SELVEDEX TRIAL

EHA Library, Annemiek Broijl, 215638

LONG-TERM OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Qaiser Bashir, 215639

THE SCREENING OF PROTEINS SIGNATURES WITH SIGNALING PATHWAY IN POLYCYTHEMIA VERA AND INHIBITION OF PIM ENHANCES JAK2 INHIBITOR SENSITIVITY

EHA Library, Wuhan Hui, 215640

IMPACT OF MOLECULAR ANALYSIS ON PROGNOSTIC SCORES IN ESSENTIAL THROMBOCYTHEMIA: A SINGLE CENTER PROSPECTIVE COHORT EXPERIENCE

EHA Library, Damien Luque Paz, 215641

THE ROLE OF THE THROMBOPOIETIN RECEPTOR (MPL) IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Kira Behrens, 215642

BOARDING ON THE SECRETARY PATHWAY IS REQUIRED FOR THE ONCOGENIC PROPERTY OF MUTANT CALRETICULIN

EHA Library, Marito Araki, 215643

PHARMACOLOGICAL INHIBITION OF IGF1R/IRS TARGETING STAT3/STAT5 SIGNALING HAS ANTI-NEOPLASTIC EFFECTS IN JAK2 V617F MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Jaqueline Fernandes, 215644

IN VIVO INHIBITION OF JAKS IN MYELOFIBROSIS IMPROVES MONOCYTES DIFFERENTIATION AND REACTIVATES PRO-INFLAMMATORY RESPONSE IN INFECTION-STIMULATED MONOCYTES

EHA Library, Lucia Catani, 215645

POLO-LIKE KINASE-1, AURORA KINASE A AND WEE1: NEW THERAPEUTIC TARGETS IN SYSTEMIC MASTOCYTOSIS

EHA Library, Manuela Mancini, 215646

NLR AS SURROGATE OF MYELOID IMMUNE SUPPRESSION CAN PREDICT EARLY SPLENIC RESPONSE TO RUXOLITINIB IN MYELOFIBROSIS

EHA Library, Alfio Bonanno, 215647

POSSIBLE SOMATIC MOSAICISM OF THE JAK2 GENE IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Naoki Mori, 215648

MULTICENTER SURVEY ON MANAGEMENT AND OUTCOME OF A RARE HEMATOLOGIC DISEASE: ADULT ONSET HISTIOCYTOSES.

EHA Library, Davide Lazzarotto, 215649

IS ANEMIA THE MAIN SURVIVAL MARKER IN PATIENTS WITH MYELOFIBROSIS IN THE RUXOLITINIB ERA?

EHA Library, María Isabel Montero, 215650

DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PATIENTS WITH MYELOFIBROSIS: A RETROSPECTIVE MULTICENTER EXPERIENCE OF THE RETE EMATOLOGICA LOMBARDA (IRON-M STUDY)

EHA Library, Elena Maria Elli, 215651

MYELOID AND LYMPHOID NEOPLASMS ASSOCIATED WITH PDGFRA AND PDGFRB REARRANGEMENTS: CLINICAL CORRELATES AND SURVIVAL OUTCOMES.

EHA Library, Abhishek Mangaonkar, 215652

ASSESSING SERUM ALBUMIN CONCENTRATION, LYMPHOCYTE COUNT AND PROGNOSTIC NUTRITIONAL INDEX MIGHT IMPROVE PROGNOSTICATION IN PATIENTS WITH MYELOFIBROSIS

EHA Library, Marko Lucijanic, 215653

LONG-TERM OUTCOME OF PATIENTS WITH SPLANCHNIC VEIN THROMBOSIS AND MYELOPROLIFERATIVE NEOPLASMS: A SINGLE CENTER EXPERIENCE

EHA Library, Danijela Lekovic, 215654

GENDER EFFECT ON PHENOTYPE AND GENOTYPE IN PATIENTS WITH POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: RESULTS FROM THE MYSEC PROJECT

EHA Library, Daniela Barraco, 215655

TARGETED TREATMENT WITH DIVERSE TYROSINE KINASE INHIBITORS IN PATIENTS WITH PCM1-JAK2, BCR-JAK2 AND ETV6-ABL1 POSITIVE EOSINOPHILIA-ASSOCIATED MYELOID/LYMPHOID NEOPLASMS

EHA Library, Georgia Metzgeroth, 215656

MANAGEMENT AND OUTCOME OF 25 PREGNANCIES IN WOMEN WITH POLYCYTHAEMIA VERA

EHA Library, Irene Bertozzi, 215657

PEGYLATED INTERFERON ALPHA-2B VERSUS ΑLPHA-2A FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA: EFFICACY AND SAFETY PROFILE.

EHA Library, Novella Pugliese, 215658

LIMITATIONS OF PREVIOUS PROGNOSTIC MODELS FOR THROMBOSIS AND EXPLORATION OF MODIFIED MODELS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Yoshinori Hashimoto, 215659

SERVICE EVALUATION OF PATIENTS WITH MYELOPROLIFERATIVE NEOPLASM AND SPLANCHNIC VEIN THROMBOSIS (MPN-SVT).

EHA Library, Sarah Wharin, 215660

FAMILIAL MYELOPROLIFERATIVE NEOPLASMS: A SINGLE-INSTITUTION ANALYSIS OF 22 FAMILIES

EHA Library, Margherita MAFFIOLI, 215661

THROMBOEMBOLIC EVENTS AFTER DIAGNOSIS OF POLYCYTHAEMIA VERA IN A SINGLE CENTER POPULATION

EHA Library, Natalia Curto-Garcia, 215662

MIPSS70 AND TRANSFUSION DEPENDENCE PREDICT SURVIVAL IN MYELOFIBROSIS PATIENTS TREATED WITH JAK1/2 INHIBITOR THERAPY

EHA Library, Caroline Mcnamara, 215663

JAK2 ALLELIC RATIO PREDICT HIGHER TROMBOTIC RISK IN MYELOFIBROSIS PATIENTS. A SINGLE CENTER EXPERIENCE ON 143 PATIENTS.

EHA Library, Mirko Farina, 215664

RUXOLITINIB AND HYDROXYUREA COMBINATION FOR THE TREATMENT OF MYELOFIBROSIS

EHA Library, Novella Pugliese, 215665

THE “MYMPN” PATIENT REGISTRY: VALIDATION OF A PROSPECTIVE MYELOPROLIFERATIVE NEOPLASM PATIENT REGISTRY

EHA Library, Robyn Scheber, 215666

THE RELATIONSHIP OF BODY MASS INDEX TO SYMPTOM BURDEN IN THE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Robyn Scheber, 215667

MANAGEMENT AND OUTCOME OF PATIENTS DIAGNOSED WITH POLYCYTHEMIA VERA IN YOUNG AGE

EHA Library, Giulia Bogoni, 215668

RUXOLITINIB IN MYELOFIBROSIS: A MULTICENTRE EXPERIENCE IN ENGLAND, NORTHERN IRELAND AND WALES

EHA Library, James Russell, 215669

TREATMENT STRATEGIES FOR POLYCYTHEMIA VERA: OBSERVATIONS IN A DUTCH ‘REAL-WORLD’ COHORT STUDY

EHA Library, Peter Westerweel, 215670

PREGNANCY OUTCOMES IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS – PALG (POLISH ADULT LEUKEMIA GROUP) A RETROSPECTIVE ANALYSIS

EHA Library, Bozena Sokolowska, 215671

SECOND MALIGNANCIES IN HIDROXYUREA AND INTERFERON TREATED PATIENTS

EHA Library, Telma Nascimento, 215672

CORRELATIONS BETWEEN GENETIC AND CLINICAL CHARACTERISTICS IN PATIENTS WITH PRIMARY MYELOFIBROSIS

EHA Library, Liubov Poluskina, 215673

MUTATIONAL PROFILES OF CLASSIC MYELOPROLIFERATIVE NEOPLASMS IN TAIWANESE PATIENTS: FREQUENCY AND CLINICAL CORRELATION

EHA Library, Huan-Chau Lin, 215674

SPLENIC MARGINAL ZONE B-CELL LYMPHOMAS DEPENDS ON PROGRAMMED DEATH-LIGAND 1 FOR CLONAL EMERGENCE AND ARE CONTROLLED BY T-CELLS FOR PROLIFERATION RATE

EHA Library, Nathalie Faumont, 215676

MECHANISMS CONFERRING RESISTANCE TO VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA

EHA Library, Daniela Steinbrecher, 215677

CLINICAL, PATHOLOGICAL AND MOLECULAR STUDY OF 46 PATIENTS WITH A DIAGNOSIS OF CD5-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA.

EHA Library, Vincent Allain, 215678

THE NOVEL TUMOR SUPPRESSOR SAMHD1 IS FREQUENTLY DOWNREGULATED AND CORRELATES WITH GERMINAL CENTER PHENOTYPE IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Ioanna Xagoraris, 215679

DUAL TARGETING OF BRD4 BY AZD5153 AND BCL2 BY AZD4320 FOR HIGH-RISK B-CELL LYMPHOMAS CONCOMITANTLY OVEREXPRESSING C-MYC AND BCL2

EHA Library, Junya Kuroda, 215680

INTEGRATIVE GENOME-WIDE ANALYSIS REVEALS REGULATION OF CELL PROLIFERATION INVOLVING MULTIPLE SIGNALING PATHWAYS BY BRD4-BINDING TARGET GENES IN MANTLE CELL LYMPHOMA CELL LINES.

EHA Library, Taku Tsukamoto, 215681

TRANSCRIPTOME SEQUENCING IN DIFFUSE LARGE B-CELL LYMPHOMA - RIBOSOME BIOGENESIS AND DYSREGULATION OF THE ACTIN CYTOSKELETON ARE ASSOCIATED WITH IMMUNOCHEMOTHERAPY RESISTANCE

EHA Library, Mimmie Stern, 215682

PD1-TIM3+ CELLS ARE THE PREDOMINANT POPULATION OF EXHAUSTED CD8+ CELLS IN FOLLICULAR LYMPHOMA WITH HIGH REACTIVATION POTENTIAL

EHA Library, Theodora Anagnostou, 215683

ENZYME-FREE DIGITAL COUNTING OF ENDOGENOUS CIRCULAR RNA MOLECULES IN FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUES FROM PATIENTS WITH B-CELL MALIGNANCIES

EHA Library, Mette Dahl, 215684

PROTEIN KINASE CK1 ΑLPHA SUSTAINS MANTLE CELL LYMPHOMA SURVIVAL BY IMPINGING ON BCR-LINKED SIGNALING PATHWAYS

EHA Library, Sabrina Manni, 215685

WEE1 INHIBITION ENHANCES ANTI-APOPTOTIC DEPENDENCY OF DIFFUSE LARGE B-CELL LYMPHOMA CAUSED BY CELL CYCLE ARREST AND DNA DAMAGE INDUCTION

EHA Library, Mathilde de Jong, 215686

INFLUENCE OF PLASMA EBV LOAD ON PROGNOSIS OF HIV-RELATED LYMPHOMAS

EHA Library, Jose Tomás Navarro Ferrando, 215687

NUCLEOLIN ENHANCED ADRIAMYCIN RESISTANCE VIA THE REGULATION OF BCL-2 EXPRESSION IN CA46 BURKITT’S LYMPHOMA CELLS

EHA Library, Jianda Hu, 215688

DOMINANT CYTOTOXIC NK CELL SUBSET WITHIN CLPD-NK PATIENTS IDENTIFIES A MORE AGGRESSIVE NK CELL PROLIFERATION

EHA Library, Gregorio Barilà, 215689

IMMUNOPROFILING OF HIV-ASSOCIATED LYMPHADENOPATHY: HIGH-THROUGHPUT ANALYSIS OF THE T CELL RECEPTOR GENE REPERTOIRE SUPPORTS EPITOPE-SPECIFIC T CELL RESPONSES

EHA Library, Evangelia Stalika, 215690

SUPERIORITY OF AVATROMBOPAG TO PLACEBO IN I REDUCING PLATELET TRANSFUSIONS IN PATIENTS WITH THROMBOCYTOPENIA AND CHRONIC LIVER DISEASE UNDERGOING SCHEDULED PROCEDURES- POOLED ANALYSIS OF 2 STUDIES

EHA Library, Kavita Aggarwal, 215691

PREDICTIVE FACTORS FOR DEVELOPING SYSTEMIC LUPUS ERYTHEMATOSUS AFTER CHILDHOOD AUTOIMMUNE CYTOPENIA

EHA Library, Nathalie Aladjidi, 215693

THE POLYMORPHISM OF CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 9 GENE MAY CONTRIBUTE TO RISK OF IMMUNE THROMBOCYTOPENIA

EHA Library, Zi Sheng, 215694

FEATURES OF PRN1008, A BRUTON’S TYROSINE KINASE INHIBITOR, IN CLINICAL DEVELOPMENT FOR IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Steven Gourlay, 215695

ATRA CORRECTS IMPAIRED MACROPHAGE FUNCTION IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA THROUGH A20/NLRP3 SIGNALING PATHWAY

EHA Library, Yun He, 215696

RH-TPO RESTORES MEGAKARYOCYTES AND BONE MARROW NICHE COMPONENTS IN THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CIRRHOSIS ASSOCIATED WITH HEPATITIS B

EHA Library, Wan-Yi Zhai, 215697

A HIGH-THROUGHPUT SCREENING ASSAY TO EVALUATE CHEMOTHERAPY-INDUCED MYELOSUPPRESSION USING HEALTHY PERIPHERAL BLOOD AND BONE MARROW

EHA Library, Dimitrios Tsallos, 215698

A NOVEL ACQUIRED RUNX1 VARIANT IS RESPONSIBLE FOR ANKRD26 DYSREGULATION AND THROMBOCYTOPENIA IN SPORADIC FORM OF MYELODYSPLASTIC SYNDROME

EHA Library, Fabrizio Vianello, 215699

FACTORS AFFECTING THROMBOPOIETIN RECEPTOR AGONIST REINITIATION AFTER DISCONTINUATION IN WELL-CONTROLLED PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN THE UK: RESULTS FROM A MODIFIED DELPHI CONSENSUS PANEL

EHA Library, Anuja Roy, 215700

IMMATURE PLATELET FRACTION (IPF): AN INTERESTING TOOL TO INVESTIGATE THROMBOCYTOPENIA

EHA Library, Zoe Van de Wyngaert, 215701

INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM IN EGYPTIAN CHILDREN AND ADOLESCENTS WITH IMMUNE THROMBOCYTOPENIA: ASSOCIATION WITH DISEASE SUSCEPTIBILITY, RESPONSE TO THERAPY AND OUTCOME

EHA Library, Mohammed Mostafa Kamel Al-tawil, 215702

CLINICAL CHARACTERISTICS AND TREATMENT COURSES FOR CYTOMEGALOVIRUS-ASSOCIATED THROMBOCYTOPENIA IN IMMUNOCOMPETENT CHILDREN AFTER NEONATAL PERIOD

EHA Library, Ye Ji Sim, 215703

RAISED EXPRESSION OF APRIL IN THE PLATELET WITH IMMUNE THROMBOCYTOPENIA AND ITS CLINICAL IMPLICATIONS

EHA Library, Yunfeng Hao, 215704

EVALUATION OF HIT SYNDROME WITH AN AUTOMATED IMMUNOASSAY IN CORRELATION WITH THE 4T SCORE IN CARDIOVASCULAR PATIENTS

EHA Library, Theoni Kanellopoulou, 215705

IMMATURE PLATELET FRACTION AS A MARKER OF THROMBOPOIESIS IN THROMBOCYTOPENIC PATIENTS

EHA Library, David J Camilleri, 215706

CHANGES IN PLATELET AGGREGATION DURING PREGNANCY AND THE IMMEDIATE POSTPARTUM PERIOD

EHA Library, Brwa Hussein, 215707

CHANGING PROFILE OF PLATELET ACTIVITY AND TURNOVER INDICES DURING TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIA: PREDICATIVE VALUE OF REPONSE BY GLYCOCALICIN AND SOLUBLE CD40 LIGAND

EHA Library, HUNG CHANG, 215708

THE IMPACT OF HIGH MOBILITY GROUP BOX 1 IN THE PATHOGENESIS OF IMMUNE THROMBOCYTOPENIA

EHA Library, Mehmet Baysal, 215709

WHAT ARE THE UNDERLYING CAUSES AND CLINICAL CHARACTERISTICS OF CHILDREN WITH REACTIVE THROMBOCYTOSIS AT A KOREAN TERTIARY MEDICAL CENTER?

EHA Library, Ye Ji Sim, 215710

STUDIES ON PLATELET FUNCTION IN A GROUP OF CLL PATIENTS DURING THE FIRST YEAR OF IBRUTINIB TREATMENT

EHA Library, Bozena Sokolowska, 215712

VALIDATION OF THE PLASMIC SCORE FOR THROMBOTIC MICROANGIOPATIES IN A SINGLE UNVERSITY HOSPITAL

EHA Library, Maria del Carmen Ballester Ruiz, 215713

OCCURRENCE AND MANAGEMENT OF HEPATOBILIARY ADVERSE EVENTS (AES) IN ADULTS WITH IMMUNE THROMBOCYTOPENIA (ITP) DURING LONG-TERM TREATMENT WITH ELTROMBOPAG: RESULTS FROM THE EXTEND STUDY

EHA Library, Abderrahim Khelif, 215714

BENEFIT OF EARLY TREATMENT WITH BLINATUMOMAB: LONG-TERM SURVIVAL OUTCOMES FOR ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING FIRST VS SUBSEQUENT SALVAGE THERAPY

EHA Library, Franziska Severin, 215715

HEALTH-RELATED QUALITY OF LIFE AND RATES OF EMERGENCY ROOM VISITS AND HOSPITALIZATION IN PATIENTS WITH AL AMYLOIDOSIS: A PROSPECTIVE ANALYSIS

EHA Library, Tiffany Quock, 215716

COST COMPARISON OF TREATMENT STRATEGIES FOLLOWING INITIATION WITH RD VERSUS VMP PLUS DARATUMUMAB IN NEWLY DIAGNOSED PATIENTS INELIGIBLE FOR ASCT

EHA Library, Graham Jackson, 215717

IMPROVABLE LIFESTYLE FACTORS IN LYMPHOMA SURVIVORS

EHA Library, Carla Minoia, 215718

QUALITY OF LIFE IN ADVANCED-STAGE,ASYMPTOMATIC,NON-BULKY FOLLICULAR LYMPHOMA TREATED WITH RITUXIMAB SHOWS SIGNIFICANT IMPROVEMENT COMPARED WITH WATCHFUL-WAITING: PHASE 3 RANDOMISED INTERNATIONAL STUDY

EHA Library, Maria A V Marzolini, 215719

HOW TO IDENTIFY PATIENTS WITH MALIGNANT HEMOPATHIES WHO DON’T BENEFIT FROM STANDARD DOSE CHEMOTHERAPY

EHA Library, Stéphanie Dubruille, 215720

THE ROLE OF MENTAL AND BEHAVIORAL DISORDERS IN LEUKEMIA PREDISPOSITION: A NATIONWIDE CASE-CONTROL STUDY

EHA Library, Hanna Moisander-Joyce, 215721

IMPACT OF CMV PROPHYLAXIS ON RATES OF REHOSPITALIZATION IN ADULT CMV SEROPOSITIVE ALLOGENEIC HSCT RECIPIENT: EXPERIENCE FROM THE LETERMOVIR PHASE 3 CLINICAL TRIAL

EHA Library, Jonathan SCHELFHOUT, 215722

QUALITY OF LIFE IN PATIENTS WITH RARE HEREDITARY HEMOLYTIC ANEMIA, THE IMPORTANCE OF SOCIAL SUPPORT

EHA Library, Stephanie van Straaten, 215723

HOW PHYSICIANS' AND PATIENTS' CHARACTERISTICS AFFECT THE LENGTH OF PATIENTS' VISIT IN THE HEMATO-ONCOLOGICAL CLINIC.

EHA Library, IRINA AMITAI, 215724

SYSTEMATIC REVIEWS OF ECONOMIC BURDEN AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML)

EHA Library, Rachel Bosshard, 215725

VENETOCLAX IMPROVES QUALITY OF LIFE FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Tara Cochrane, 215726